Pure Global

"Abbot" Efinin second generation analyzer - Taiwan Registration afc611aae9d9525830ff789543ee093c

Access comprehensive regulatory information for "Abbot" Efinin second generation analyzer in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number afc611aae9d9525830ff789543ee093c and manufactured by Abbott Diagnostics Technologies AS. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
afc611aae9d9525830ff789543ee093c
Registration Details
Taiwan FDA Registration: afc611aae9d9525830ff789543ee093c
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

"Abbot" Efinin second generation analyzer
TW: โ€œไบžๅŸนโ€่‰พ่ฒๅฏง็ฌฌไบŒไปฃๅˆ†ๆžๅ„€
Risk Class 2

Registration Details

afc611aae9d9525830ff789543ee093c

DHA05603312101

Company Information

Product Details

This product is a fully automated multi-test analyzer and is only suitable for use with Afinion test cards.

B Hematology, pathology, and genetics

B.7470 Analysis of glycosylated hemoglobin

import

Dates and Status

Jan 02, 2020

Jan 02, 2030